|
Volumn 32, Issue 3 SUPPL. 1, 2000, Pages S27-S44
|
Neoral use in the cardiac transplant recipient
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
GRANZYME A;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MONITORING;
DRUG SAFETY;
DRUG WITHDRAWAL;
EDEMA;
ELECTROCARDIOGRAM;
GASTROINTESTINAL SYMPTOM;
GINGIVA HYPERPLASIA;
GRAFT REJECTION;
HEART MUSCLE BIOPSY;
HEART TRANSPLANTATION;
HUMAN;
HYPERTENSION;
HYPERTRICHOSIS;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
LYMPHOPROLIFERATIVE DISEASE;
MAINTENANCE THERAPY;
MORTALITY;
NEOPLASM;
NEPHROTOXICITY;
PARESTHESIA;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
VASCULAR DISEASE;
|
EID: 0034192284
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)00862-9 Document Type: Article |
Times cited : (40)
|
References (80)
|